Bone marrow transplantation in 65 patients with severe aplastic anemia. 1981

E Gluckman, and A Devergie, and I Gerotta, and J Hors, and M Sasportes, and M Boiron, and J Bernard

This articles summarizes the experience of the Hospital Saint-Louis Bone Marrow Transplantation Team of bone marrow transplantation in severe aplastic anemia. Sixty-five consecutive patients have been transplanted with an HLA identical sibling marrow. Various conditioning regimen have been used. Conditioning regimen using high dose Cyclophosphamide alone or associated with Procarbazine and anti-thymocyte globulin gave a high number of bone marrow graft rejection. Therefore, a conditioning regimen using Cyclophosphamide and total body irradiation with lung shielding has been used for the last three years. This regimen suppressed bone marrow graft rejection. The main problems remain graft versus host disease and intercurrent infections. Despite these complications, 50 per cent of the patients become long term survivors and are apparently cured of their initial disease.

UI MeSH Term Description Entries
D011344 Procarbazine An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease. Matulane,Natulan,Procarbazine Hydrochloride,Procarbazine Monohydrobromide,Procarbazine Monohydrochloride,Hydrochloride, Procarbazine,Monohydrobromide, Procarbazine,Monohydrochloride, Procarbazine
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E Gluckman, and A Devergie, and I Gerotta, and J Hors, and M Sasportes, and M Boiron, and J Bernard
December 1977, Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg,
E Gluckman, and A Devergie, and I Gerotta, and J Hors, and M Sasportes, and M Boiron, and J Bernard
April 1986, Deutsche medizinische Wochenschrift (1946),
E Gluckman, and A Devergie, and I Gerotta, and J Hors, and M Sasportes, and M Boiron, and J Bernard
July 1988, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
E Gluckman, and A Devergie, and I Gerotta, and J Hors, and M Sasportes, and M Boiron, and J Bernard
December 1993, Journal of the Formosan Medical Association = Taiwan yi zhi,
E Gluckman, and A Devergie, and I Gerotta, and J Hors, and M Sasportes, and M Boiron, and J Bernard
January 1998, Medicina,
E Gluckman, and A Devergie, and I Gerotta, and J Hors, and M Sasportes, and M Boiron, and J Bernard
August 1991, Bone marrow transplantation,
E Gluckman, and A Devergie, and I Gerotta, and J Hors, and M Sasportes, and M Boiron, and J Bernard
March 1981, JAMA,
E Gluckman, and A Devergie, and I Gerotta, and J Hors, and M Sasportes, and M Boiron, and J Bernard
April 1996, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
E Gluckman, and A Devergie, and I Gerotta, and J Hors, and M Sasportes, and M Boiron, and J Bernard
January 1975, Hamatologie und Bluttransfusion,
E Gluckman, and A Devergie, and I Gerotta, and J Hors, and M Sasportes, and M Boiron, and J Bernard
August 1993, Transplantation proceedings,
Copied contents to your clipboard!